Pharmaceuticals (29) | Distribution Agreements (29)

Browse by Company

Recent Contracts

Amendment No. 4, dated as of April 18, 2022 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts... (Jazz Pharmaceuticals plc, Filed With SEC on May 4, 2022)
PrimeX Distribution Agreement (Canbiola, Inc., Filed With SEC on April 15, 2022)
Distribution Agreement (MICROCHANNEL TECHNOLOGIES CORP, Filed With SEC on November 12, 2021)
Amendment No. 1 to Distribution Agreement Between Respirent Pharmaceuticals Co. Ltd. and Lannett Company, Inc (Lannett Company, Inc., Filed With SEC on August 26, 2021)
Distribution Agreement Between Respirent Pharmaceuticals Co. Ltd. and Lannett Company, Inc (Lannett Company, Inc., Filed With SEC on August 26, 2021)
Amendment No. 1, dated as of July 4, 2021 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty... (Jazz Pharmaceuticals plc, Filed With SEC on August 3, 2021)
Amendment No. 2, dated as of July 19, 2021 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty... (Jazz Pharmaceuticals plc, Filed With SEC on August 3, 2021)
Co-Development and Distribution Agreement, by and between Leading BioSciences, Inc. and Newsoara Biopharma Co., Ltd. (as successor-in-interest to Biolead Medical Technology... (Neuralstem, Inc., Filed With SEC on December 23, 2020)
Licensing and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Gabriel Science, LLC, effective December 14, 2020 (Sonoma Pharmaceuticals, Inc., Filed With SEC on December 17, 2020)
Exclusive Licensing and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Crown Laboratories, Inc., effective December 4, 2020 (Sonoma Pharmaceuticals, Inc., Filed With SEC on December 10, 2020)